Skip to content

Development of e-learning system for endoscopic diagnosis of gastric cancer: an international multicenter trial

Development of e-learning system for endoscopic diagnosis of gastric cancer: an international multicenter trial - Global e-Endo Study Team (GEST)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000010283
Enrollment
200
Registered
2013-03-21
Start date
2013-03-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

E-learning system no

Sponsors

Funds from the Central Research Institute of Fukuoka University (I)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) The supplied e-test and e-learning samples must display and operate correctly on the web browser on the participants' computer. 2) Participants must have sufficient English skills to understand the e-test and e-learning materials. 3) Participants must complete the pre questionnaire in full within a month. 4) Participants must submit a signed consent form for participation in the study.

Exclusion criteria

Exclusion criteria: This study is designed to evaluate the effectiveness (in terms of learning outcomes) of the e-learning system for medical practitioners who have not received adequate training in the endoscopic diagnosis of early gastric cancer. Accordingly, medical practitioners who score 80% or more on the pre-test will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Internet-based e-tests are undertaken before and after e-learning in order to assess the primary endpoint of degree of improvement in test scores.

Secondary

MeasureTime frame
The difference between early gastric cancer detection rates in the pre-learning and post-learning periods comprises the secondary endpoint.

Countries

Asia(except Japan),South America,Australia,Europe

Contacts

Public ContactHideki Ishikawa

Kyoto Prefectural University of Medicine Department of Molecular-Targeting Cancer Prevention

cancer@gol.com06-6202-5444

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026